Login here to update your profile  
My Profile

Jeffrey Krischer,  PHD

Administrative Appointment: Division Chief

Distinguished Prof & Director

Distinguished Professor

profile Image
Email: jkrische@health.usf.edu
Phone: (813) 396-9512
Office: HLM, 201
Mailing address 3650 Spectrum Blvd
Tampa, FL 33612
View My C. V.
  • PHD, Applied Mathematics, Harvard University , Cambridge, United States - 1974.

    Selected Publications
  • Richesson, RL.Andrews, JE.Krischer, JP. Use of SNOMED CT to represent clinical research data: a semantic characterization of data items on case report forms in vasculitis research. Journal of the American Medical Informatics Association : JAMIA. 13(5): 536-46, .
  • Andrews, JE.Richesson, RL.Krischer, J. Variation of SNOMED CT coding of clinical research concepts among coding experts. Journal of the American Medical Informatics Association : JAMIA. 14(4): 497-506, .
  • Richesson, RL.Krischer, J. Data standards in clinical research: gaps, overlaps, challenges and future directions. Journal of the American Medical Informatics Association : JAMIA. 14(6): 687-96, .
  • Roetzheim, RG.Christman, LK.Jacobsen, PB.Cantor, AB.Schroeder, J.Abdulla, R.Hunter, S.Chirikos, TN.Krischer, JP. A randomized controlled trial to increase cancer screening among attendees of community health centers. Annals of family medicine. 2(4): 294-300, .
  • Knowles, MR.Ostrowski, LE.Leigh, MW.Sears, PR.Davis, SD.Wolf, WE.Hazucha, MJ.Carson, JL.Olivier, KN.Sagel, SD.Rosenfeld, M.Ferkol, TW.Dell, SD.Milla, CE.Randell, SH.Yin, W.Sannuti, A.Metjian, HM.Noone, PG.Noone, PJ.Olson, CA.Patrone, MV.Dang, H.Lee, HS.Hurd, TW.Gee, HY.Otto, EA.Halbritter, J.Kohl, S.Kircher, M.Krischer, J.Bamshad, MJ.Nickerson, DA.Hildebrandt, F.Shendure, J.Zariwala, MA. Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. American journal of respiratory and critical care medicine. 189(6): 707-17, 2014.
  • Pescovitz, MD.Greenbaum, CJ.Bundy, B.Becker, DJ.Gitelman, SE.Goland, R.Gottlieb, PA.Marks, JB.Moran, A.Raskin, P.Rodriguez, H.Schatz, DA.Wherrett, DK.Wilson, DM.Krischer, JP.Skyler, JS. B-lymphocyte depletion with rituximab and β-cell function: two-year results. Diabetes care. 37(2): 453-9, 2014.
  • Elding Larsson, H.Vehik, K.Gesualdo, P.Akolkar, B.Hagopian, W.Krischer, J.Lernmark, Å.Rewers, M.Simell, O.She, JX.Ziegler, A.Haller, MJ. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatric diabetes. 15(2): 118-26, 2014.
  • Orban, T.Bundy, B.Becker, DJ.Dimeglio, LA.Gitelman, SE.Goland, R.Gottlieb, PA.Greenbaum, CJ.Marks, JB.Monzavi, R.Moran, A.Peakman, M.Raskin, P.Russell, WE.Schatz, D.Wherrett, DK.Wilson, DM.Krischer, JP.Skyler, JS. Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment. Diabetes care. 37(4): 1069-75, 2014.
  • Langford, CA.Monach, PA.Specks, U.Seo, P.Cuthbertson, D.McAlear, CA.Ytterberg, SR.Hoffman, GS.Krischer, JP.Merkel, PA. An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's). Annals of the rheumatic diseases. 73(7): 1376-9, 2014.
  • Hadley, D.Cheung, RK.Becker, DJ.Girgis, R.Palmer, JP.Cuthbertson, D.Krischer, JP.Dosch, HM. Large-scale prospective T cell function assays in shipped, unfrozen blood samples: experiences from the multicenter TRIGR trial. Clinical and vaccine immunology : CVI. 21(2): 203-11, 2014.
  • Lee, HS.Burkhardt, BR.McLeod, W.Smith, S.Eberhard, C.Lynch, K.Hadley, D.Rewers, M.Simell, O.She, JX.Hagopian, B.Lernmark, A.Akolkar, B.Ziegler, AG.Krischer, JP. Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes/metabolism research and reviews. 30(5): 424-34, 2014.
  • Sosenko, JM.Skyler, JS.Mahon, J.Krischer, JP.Greenbaum, CJ.Rafkin, LE.Beam, CA.Boulware, DC.Matheson, D.Cuthbertson, D.Herold, KC.Eisenbarth, G.Palmer, JP. Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes. Diabetes care. 37(4): 979-84, 2014.
  • Xu, P.Qian, X.Schatz, DA.Cuthbertson, D.Krischer, JP. Distribution of C-peptide and its determinants in North American children at risk for type 1 diabetes. Diabetes care. 37(7): 1959-65, 2014.
  • Batshaw, ML.Groft, SC.Krischer, JP. Research into rare diseases of childhood. JAMA. 311(17): 1729-30, 2014.
  • Knip, M.Åkerblom, HK.Becker, D.Dosch, HM.Dupre, J.Fraser, W.Howard, N.Ilonen, J.Krischer, JP.Kordonouri, O.Lawson, ML.Palmer, JP.Savilahti, E.Vaarala, O.Virtanen, SM. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA. 311(22): 2279-87, 2014.
  • Lin, Y.Qian, X.Krischer, J.Vehik, K.Lee, HS.Huang, S. A rule-based prognostic model for type 1 diabetes by identifying and synthesizing baseline profile patterns. PloS one. 9(6): e91095, 2014.
  • Krischer, JP. The use of intermediate endpoints in the design of type 1 diabetes prevention trials. Diabetologia. 56(9): 1919-24, 2013.
  • Vehik, K.Fiske, SW.Logan, CA.Agardh, D.Cilio, CM.Hagopian, W.Simell, O.Roivainen, M.She, JX.Briese, T.Oikarinen, S.Hyoty, H.Ziegler, AG.Rewers, M.Lernmark, A.Akolkar, B.Krischer, JP.Burkhardt, BR. Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes/metabolism research and reviews. 29(7): 557-67, 2013.
  • Moran, A.Bundy, B.Becker, DJ.DiMeglio, LA.Gitelman, SE.Goland, R.Greenbaum, CJ.Herold, KC.Marks, JB.Raskin, P.Sanda, S.Schatz, D.Wherrett, DK.Wilson, DM.Krischer, JP.Skyler, JS.Pickersgill, L.de Koning, E.Ziegler, AG.Böehm, B.Badenhoop, K.Schloot, N.Bak, JF.Pozzilli, P.Mauricio, D.Donath, MY.Castaño, L.Wägner, A.Lervang, HH.Perrild, H.Mandrup-Poulsen, T. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet. 381(9881): 1905-15, 2013.
  • Young, L.Lee, HS.Inoue, Y.Moss, J.Singer, LG.Strange, C.Nakata, K.Barker, AF.Chapman, JT.Brantly, ML.Stocks, JM.Brown, KK.Lynch, JP.Goldberg, HJ.Downey, GP.Swigris, JJ.Taveira-DaSilva, AM.Krischer, JP.Trapnell, BC.McCormack, FX. Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. The Lancet. Respiratory medicine. 1(6): 445-52, 2013.
  • Quenan, S.Strueven, V.Saxer, N.Laffitte, E.Kaya, G.Krischer, J.Hafezi, F.Le Gal, FA. Pruritic acquired nevus of Ota. Dermatology (Basel, Switzerland). 227(2): 186-8, 2013.
  • Adl, AA.Qian, X.Xu, P.Vehik, K.Krischer, JP. Feature ranking based on synergy networks to identify prognostic markers in DPT-1. EURASIP journal on bioinformatics & systems biology. 2013(1): 12, 2013.
  • Leigh, MW.Hazucha, MJ.Chawla, KK.Baker, BR.Shapiro, AJ.Brown, DE.Lavange, LM.Horton, BJ.Qaqish, B.Carson, JL.Davis, SD.Dell, SD.Ferkol, TW.Atkinson, JJ.Olivier, KN.Sagel, SD.Rosenfeld, M.Milla, C.Lee, HS.Krischer, J.Zariwala, MA.Knowles, MR. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Annals of the American Thoracic Society. 10(6): 574-81, 2013.
  • Sosenko, JM.Skyler, JS.Beam, CA.Krischer, JP.Greenbaum, CJ.Mahon, J.Rafkin, LE.Matheson, D.Herold, KC.Palmer, JP. Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes. 62(12): 4179-83, 2013.
  • Sosenko, JM.Skyler, JS.Palmer, JP.Krischer, JP.Yu, L.Mahon, J.Beam, CA.Boulware, DC.Rafkin, L.Schatz, D.Eisenbarth, G. The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes care. 36(9): 2615-20, 2013.
  • Ashizawa, T.Figueroa, KP.Perlman, SL.Gomez, CM.Wilmot, GR.Schmahmann, JD.Ying, SH.Zesiewicz, TA.Paulson, HL.Shakkottai, VG.Bushara, KO.Kuo, SH.Geschwind, MD.Xia, G.Mazzoni, P.Krischer, JP.Cuthbertson, D.Holbert, AR.Ferguson, JH.Pulst, SM.Subramony, SH. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet journal of rare diseases. 8(): 177, 2013.
  • Monach, PA.Warner, RL.Tomasson, G.Specks, U.Stone, JH.Ding, L.Fervenza, FC.Fessler, BJ.Hoffman, GS.Iklé, D.Kallenberg, CG.Krischer, J.Langford, CA.Mueller, M.Seo, P.St Clair, EW.Spiera, R.Tchao, N.Ytterberg, SR.Johnson, KJ.Merkel, PA. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Annals of the rheumatic diseases. 72(8): 1342-50, 2013.
  • Akers, AL.Ball, KL.Clancy, M.Comi, AM.Faughnan, ME.Gopal-Srivastava, R.Jacobs, TP.Kim, H.Krischer, J.Marchuk, DA.McCulloch, CE.Morrison, L.Moses, M.Moy, CS.Pawlikowska, L.Young, WL. Brain Vascular Malformation Consortium: Overview, Progress and Future Directions. The Journal of rare disorders. 1(1): 5, 2013.
  • Lee, HS.Briese, T.Winkler, C.Rewers, M.Bonifacio, E.Hyoty, H.Pflueger, M.Simell, O.She, JX.Hagopian, W.Lernmark, A.Akolkar, B.Krischer, JP.Ziegler, AG. Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia. 56(8): 1705-11, 2013.
  • Vehik, K.Cuthbertson, D.Boulware, D.Beam, CA.Rodriguez, H.Legault, L.Hyytinen, M.Rewers, MJ.Schatz, DA.Krischer, JP. Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth. Diabetes care. 35(9): 1821-5, 2012.
  • Shurin, S.Krischer, J.Groft, SC. Clinical trials In BMT: ensuring that rare diseases and rarer therapies are well done. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(1 Suppl): S8-11, 2012.
  • Monach, PA.Kümpers, P.Lukasz, A.Tomasson, G.Specks, U.Stone, JH.Cuthbertson, D.Krischer, J.Carette, S.Ding, L.Hoffman, GS.Iklé, D.Kallenberg, CG.Khalidi, NA.Langford, CA.Seo, P.St Clair, EW.Spiera, R.Tchao, N.Ytterberg, SR.Haubitz, M.Merkel, PA. Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis. PloS one. 7(1): e30197, 2012.
  • Richesson, RL.Sutphen, R.Shereff, D.Krischer, JP. The Rare Diseases Clinical Research Network Contact Registry update: features and functionality. Contemporary clinical trials. 33(4): 647-56, 2012.
  • Sosenko, JM.Skyler, JS.Mahon, J.Krischer, JP.Beam, CA.Boulware, DC.Greenbaum, CJ.Rafkin, LE.Cowie, C.Cuthbertson, D.Palmer, JP. The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes. Diabetes care. 35(7): 1552-5, 2012.
  • Nucci, AM.Becker, DJ.Virtanen, SM.Cuthbertson, D.Softness, B.Huot, C.Wasikowa, R.Dosch, HM.Akerblom, HK.Knip, M. Growth differences between North American and European children at risk for type 1 diabetes. Pediatric diabetes. 13(5): 425-31, 2012.
  • Couluris, M.Kinder, BW.Xu, P.Gross-King, M.Krischer, J.Panos, RJ. Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project. Lung. 190(5): 523-7, 2012.
  • Xu, P.Beam, CA.Cuthbertson, D.Sosenko, JM.Skyler, JS.Krischer, JP. Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis. Diabetes care. 35(10): 1975-80, 2012.
  • Yu, L.Boulware, DC.Beam, CA.Hutton, JC.Wenzlau, JM.Greenbaum, CJ.Bingley, PJ.Krischer, JP.Sosenko, JM.Skyler, JS.Eisenbarth, GS.Mahon, JL. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes care. 35(6): 1213-8, 2012.
  • Vehik, K.Cuthbertson, D.Ruhlig, H.Schatz, DA.Peakman, M.Krischer, JP. Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial. Diabetes care. 34(7): 1585-90, 2011.
  • Vehik, K.Beam, CA.Mahon, JL.Schatz, DA.Haller, MJ.Sosenko, JM.Skyler, JS.Krischer, JP. Development of autoantibodies in the TrialNet Natural History Study. Diabetes care. 34(9): 1897-901, 2011.
  • Lee, HS.Paik, MC.Rundek, T.Sacco, RL.Dong, C.Krischer, JP. Heritability Estimation using Regression Models for Correlation. Journal of biometrics & biostatistics. 2(119): , 2011.
  • Vehik, K.Haller, MJ.Beam, CA.Schatz, DA.Wherrett, DK.Sosenko, JM.Krischer, JP. Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood. Diabetes care. 34(2): 358-62, 2011.
  • Richesson, RL.Smith, SB.Malloy, J.Krischer, JP. Achieving standardized medication data in clinical research studies: two approaches and applications for implementing RxNorm. Journal of medical systems. 34(4): 651-7, 2010.
  • Sosenko, JM.Mahon, J.Rafkin, L.Lachin, JM.Krause-Steinrauf, H.Krischer, JP.Cuthbertson, D.Palmer, JP.Thompson, C.Greenbaum, CJ.Skyler, JS. A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants. Pediatric diabetes. (): , 2010.
  • Sosenko, JM.Palmer, JP.Rafkin, LE.Krischer, JP.Cuthbertson, D.Greenbaum, CJ.Eisenbarth, G.Skyler, JS. Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes care. 33(3): 620-5, 2010.
  • Tazawa, R.Trapnell, BC.Inoue, Y.Arai, T.Takada, T.Nasuhara, Y.Hizawa, N.Kasahara, Y.Tatsumi, K.Hojo, M.Ishii, H.Yokoba, M.Tanaka, N.Yamaguchi, E.Eda, R.Tsuchihashi, Y.Morimoto, K.Akira, M.Terada, M.Otsuka, J.Ebina, M.Kaneko, C.Nukiwa, T.Krischer, JP.Akazawa, K.Nakata, K. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. American journal of respiratory and critical care medicine. 181(12): 1345-54, 2010.
  • Bonifacio, E.Yu, L.Williams, AK.Eisenbarth, GS.Bingley, PJ.Marcovina, SM.Adler, K.Ziegler, AG.Mueller, PW.Schatz, DA.Krischer, JP.Steffes, MW.Akolkar, B. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. The Journal of clinical endocrinology and metabolism. 95(7): 3360-7, 2010.
  • Levis, S.Strickman-Stein, N.Doerge, DR.Krischer, J. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women. Contemporary clinical trials. 31(4): 293-302, 2010.
  • Xu, P.Wu, Y.Zhu, Y.Dagne, G.Johnson, G.Cuthbertson, D.Krischer, JP.Sosenko, JM.Skyler, JS. Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes care. 33(12): 2508-13, 2010.
  • Seminara, J.Tuchman, M.Krivitzky, L.Krischer, J.Lee, HS.Lemons, C.Baumgartner, M.Cederbaum, S.Diaz, GA.Feigenbaum, A.Gallagher, RC.Harding, CO.Kerr, DS.Lanpher, B.Lee, B.Lichter-Konecki, U.McCandless, SE.Merritt, JL.Oster-Granite, ML.Seashore, MR.Stricker, T.Summar, M.Waisbren, S.Yudkoff, M.Batshaw, ML. Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium. Molecular genetics and metabolism. 100 Suppl 1(): S97-105, 2010.
  • Sorkio, S.Cuthbertson, D.Bärlund, S.Reunanen, A.Nucci, AM.Berseth, CL.Koski, K.Ormisson, A.Savilahti, E.Uusitalo, U.Ludvigsson, J.Becker, DJ.Dupré, J.Krischer, JP.Knip, M.Akerblom, HK.Virtanen, SM. Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial. Diabetes/metabolism research and reviews. 26(3): 206-11, 2010.
  • Orban, T.Sosenko, JM.Cuthbertson, D.Krischer, JP.Skyler, JS.Jackson, R.Yu, L.Palmer, JP.Schatz, D.Eisenbarth, G. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes care. 32(12): 2269-74, 2009.
  • Sosenko, JM.Palmer, JP.Rafkin-Mervis, L.Krischer, JP.Cuthbertson, D.Mahon, J.Greenbaum, CJ.Cowie, CC.Skyler, JS. Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1. Diabetes care. 32(9): 1603-7, 2009.
  • Roesch, LF.Casella, G.Simell, O.Krischer, J.Wasserfall, CH.Schatz, D.Atkinson, MA.Neu, J.Triplett, EW. Influence of fecal sample storage on bacterial community diversity. The open microbiology journal. 3(): 40-6, 2009.
  • Richesson, RL.Lee, HS.Cuthbertson, D.Lloyd, J.Young, K.Krischer, JP. An automated communication system in a contact registry for persons with rare diseases: scalable tools for identifying and recruiting clinical research participants. Contemporary clinical trials. 30(1): 55-62, 2009.
  • Uchida, K.Nakata, K.Suzuki, T.Luisetti, M.Watanabe, M.Koch, DE.Stevens, CA.Beck, DC.Denson, LA.Carey, BC.Keicho, N.Krischer, JP.Yamada, Y.Trapnell, BC. Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy individuals. Blood. (): , 2008.
  • Sosenko, JM.Palmer, JP.Rafkin-Mervis, L.Krischer, JP.Cuthbertson, D.Matheson, D.Skyler, JS. Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes care. 31(11): 2188-92, 2008.
  • Moyers, S.Richesson, R.Krischer, J. Trans-atlantic data harmonization in the classification of medicines and dietary supplements: a challenge for epidemiologic study and clinical research. International journal of medical informatics. 77(1): 58-67, 2008.
  • Andrews, JE.Patrick, TB.Richesson, RL.Brown, H.Krischer, JP. Comparing heterogeneous SNOMED CT coding of clinical research concepts by examining normalized expressions. Journal of biomedical informatics. 41(6): 1062-9, 2008.
  • Richesson, RL.Fung, KW.Krischer, JP. Heterogeneous but "standard" coding systems for adverse events: Issues in achieving interoperability between apples and oranges. Contemporary clinical trials. 29(5): 635-45, 2008.
  • Kumar, NB.Besterman-Dahan, K.Kang, L.Pow-Sang, J.Xu, P.Allen, K.Riccardi, D.Krischer, JP. Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy. Clinical medicine. Urology [electronic resource]. 1(): 1-14, 2008.
  • Richesson, RL.Malloy, JF.Paulus, K.Cuthbertson, D.Krischer, JP. An automated standardized system for managing adverse events in clinical research networks. Drug safety : an international journal of medical toxicology and drug experience. 31(10): 807-22, 2008.
  • Couluris, M.Mayer, JL.Freyer, DR.Sandler, E.Xu, P.Krischer, JP. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia. Journal of pediatric hematology/oncology. 30(11): 791-7, 2008.
  • Krischer, MM.Xu, P. Determinants of psychological functioning in patients undergoing radiotherapy: a descriptive study. Journal of psychosocial oncology. 26(4): 1-13, 2008.
  • Inoue, Y.Trapnell, BC.Tazawa, R.Arai, T.Takada, T.Hizawa, N.Kasahara, Y.Tatsumi, K.Hojo, M.Ichiwata, T.Tanaka, N.Yamaguchi, E.Eda, R.Oishi, K.Tsuchihashi, Y.Kaneko, C.Nukiwa, T.Sakatani, M.Krischer, JP.Nakata, K. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. American journal of respiratory and critical care medicine. 177(7): 752-62, 2008.
  • Xu, P.Cuthbertson, D.Greenbaum, C.Palmer, JP.Krischer, JP. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes care. 30(9): 2314-20, 2007.
  • Krischer, MM.Xu, P.Meade, CD.Jacobsen, PB. Self-administered stress management training in patients undergoing radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(29): 4657-62, 2007.
  • Richesson, R.Syed, A.Guillette, H.Tuttle, MS.Krischer, J. A web-based SNOMED CT browser: distributed and real-time use of SNOMED CT during the clinical research process. Studies in health technology and informatics. 129(Pt 1): 631-5, 2007.
  • Richesson, RL.Young, K.Lloyd, J.Adams, T.Guillette, H.Malloy, J.Krischer, JP. An automated communication system in a Contact Registry for persons with rare diseases: tools for retaining potential clinical research participants. AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium. (): 1094, 2007.
  • Richesson, R.Young, K.Guillette, H.Tuttle, M.Abbondondolo, M.Krischer, J. Standard terminology on demand: facilitating distributed and real-time use of SNOMED CT during the clinical research process. AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium. (): 1076, 2006.
  • Krischer, JP.Cuthbertson, DD.Greenbaum, C. Male sex increases the risk of autoimmunity but not type 1 diabetes. Diabetes care. 27(8): 1985-90, 2004.
  • Fink, E.Kokku, PK.Nikiforou, S.Hall, LO.Goldgof, DB.Krischer, JP. Selection of patients for clinical trials: an interactive web-based system. Artificial intelligence in medicine. 31(3): 241-54, 2004.
  • Krischer, J. The biostatistics of prediction. Autoimmunity. 37(4): 261-3, 2004.
  • Sutphen, R.Xu, Y.Wilbanks, GD.Fiorica, J.Grendys, EC.LaPolla, JP.Arango, H.Hoffman, MS.Martino, M.Wakeley, K.Griffin, D.Blanco, RW.Cantor, AB.Xiao, YJ.Krischer, JP. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 13(7): 1185-91, 2004.
  • Krischer, JP.Cuthbertson, DD.Yu, L.Orban, T.Maclaren, N.Jackson, R.Winter, WE.Schatz, DA.Palmer, JP.Eisenbarth, GS. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. The Journal of clinical endocrinology and metabolism. 88(1): 103-8, 2003.
  • Chirikos, TN.Ruckdeschel, JC.Krischer, JP. Impact of clinical trials on the cost of cancer care. Medical care. 39(4): 373-83, 2001.
  • Roetzheim, RG.Pal, N.van Durme, DJ.Wathington, D.Ferrante, JM.Gonzalez, EC.Krischer, JP. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. Journal of the American Academy of Dermatology. 43(2 Pt 1): 211-8, 2000.
  • Roetzheim, RG.Pal, N.Gonzalez, EC.Ferrante, JM.Van Durme, DJ.Krischer, JP. Effects of health insurance and race on colorectal cancer treatments and outcomes. American journal of public health. 90(11): 1746-54, 2000.
  • Roetzheim, RG.Gonzalez, EC.Ferrante, JM.Pal, N.Van Durme, DJ.Krischer, JP. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 89(11): 2202-13, 2000.
  • Roetzheim, RG.Pal, N.Tennant, C.Voti, L.Ayanian, JZ.Schwabe, A.Krischer, JP. Effects of health insurance and race on early detection of cancer. Journal of the National Cancer Institute. 91(16): 1409-15, 1999.
  • Roetzheim, RG.Pal, N.Gonzalez, EC.Ferrante, JM.Van Durme, DJ.Ayanian, JZ.Krischer, JP. The effects of physician supply on the early detection of colorectal cancer. The Journal of family practice. 48(11): 850-8, 1999.
  • Cantor, AB.Krischer, JP.Cuthbertson, DD.Schatz, DA.Riley, WJ.Malone, J.Schwartz, S.Quattrin, T.Maclaren, NK. Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM. The Journal of clinical endocrinology and metabolism. 80(12): 3739-43, 1995.
  • Papaconstantinou, C.Krischer, JP. An automated patient registration and treatment randomization system. Journal of medical systems. 19(6): 445-56, 1995.

  • Profile last modified on 06/06/2015